Lipid drug pharmacology Flashcards
Statin MOA
HMG CoA reductase inhibitor
Reduce cholesterol synthesis
Increase hepatic cholesterol uptake
Reduce LDL, modest TAG, increase HDL
SE: myositis, deranged LFTs
Ezetimibe MOA
Decreased cholesterol absorption in small intestine
-blocks the critical mediator of cholesterol absorption, the Niemann-Pick C1-like 1 (NPC1L1) protein on the gastrointestinal tract epithelial cells as well as in hepatocytes
This means LDL receptors upregulated so taken up from blood so less atherogenic.
SE: headache
Nicotinic acid MOA
Probably reduce fatty acid releast from peripheral adipose tissue.
Reduce LDL and TAG
Increase HDL
Lower potentially atherogenic lipoprotein
Decrease hepatic VLDL secretion
Decrease TAG synthesis overall by reducing fatty acid synthesis
Also reduce HDL catabolism so more garbage collectors working
AKA vitamin B3
SE: flushing, myositis
Fibrates
Agonist of PPAR-alpha–>increase lipoprotein lipase expression (increase VLDL to IDL)
SE: myositis, pruritis, cholestasis
Reduce TAG
Modest increase HDL
Variable LDL
Cholestyramine
Decreases bile acid reabsorption in the small intestine, upregulating the amount of cholesterol that is converted to bile acid
SE: GI
Au targets for lipids?
LDL under 1.8
HDL over 1
Triglycerides under 2
NonHDL under 2.5
When should you start assessing someone with Framingham risk assessment for CV risk?
Caucasian over age 45 or A/TSI over 35 and none of the high risk features which automatically shuttle the person to a high risk group -Diabetic over 60 -Microalbumin -180/110 higher than -CKD with GFR under 45 Chol over 7.5 -Familial hypercholesterolaemia -Or A/TSI over age 74 -->this means already have over 15% risk CVD within next 5 years
If then calculated to be moderate risk (10-15% CVD over 5 years)- review in 6-12 months
Low risk calculate every 2 years
What are you allowed to combine with a statin?
Ezetimibe -safe- this reduces LDLs
Fenofibrate better than gemfibrozil with statin as reduces risk of myopathy
Bile acid binding resin
Nicotinic acid